Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine Treatment
Increasing numbers of individuals with opioid use disorder (OUD) are insured by Medicaid. Little is known about whether providers of buprenorphine, an evidence-based OUD pharmacotherapy, accept this type of payment. Data are scant regarding whether Medicaid acceptance varies by physician and state-level characteristics. To address these gaps, national survey data from 1174 buprenorphine-prescribing physicians (BPPs) and state characteristics were examined in a multi-level model of Medicaid acceptance. Only 52.0% of BPPs accepted Medicaid for buprenorphine-related office visits. Specialists in addiction and psychiatry were significantly less likely to accept Medicaid than other specialties, as were BPPs delivering buprenorphine in individual medical practice. Perceived adequacy of Medicaid reimbursement was positively associated with accepting Medicaid. Medicaid acceptance was not associated with states’ implementation of the Medicaid expansion. Individuals who are covered by Medicaid may face barriers to accessing buprenorphine treatment, which has high public health significance given the ongoing opioid epidemic.
This study was supported by funding from the National Institute on Drug Abuse (NIDA Grant R33DA035641), an institute within the National Institutes of Health (NIH). The use of REDCap was supported by a grant from the National Center for Advancing Translational Sciences (NIH CTSA UL1TR000117). The content of this manuscript is solely the responsibility of the authors and does not represent the official views of the NIH or NIDA. The authors gratefully acknowledge the physicians who participated in the study and the efforts of the research staff: Jennifer Cook, Eric Shelton, Diana Norkus, Danielle Rosenkrantz, Jorge Masson, Joseph Calvert, and Haley Clark.
Compliance with Ethical Standards
Conflicts of Interest
The authors declare that they have no conflicts of interest.
- 5.Rudd RA, Aleshire N, Zibbell JE, et al. Increases in drug and opioid overdose deaths - United States, 2000-2014. MMWR: Morbidity and Mortality Weekly Report. 2016;64(50–51):1378–1382.Google Scholar
- 6.Paulozzi LJ, Mack KA, Hockenberry JM. Vital signs: Variation among states in prescribing of opioid pain relievers and benzodiazapines--United States, 2012. MMWR: Morbidity and Mortality Weekly Report. 2014;63:563–568.Google Scholar
- 24.Clark RE, Baxter JD, Barton BA, et al. The impact of prior authorization on buprenorphine dose, relapse rates, and cost for Massachusetts Medicaid beneficiaries with opioid dependence. Health Services Research. 2014;49(6):1964–1979.Google Scholar
- 29.Rinaldo SG, Rinaldo DW. Availability Without Accessibility? State Medicaid Coverage and Authorization Requirements for Opioid Dependence Medications. Available online at https://web.archive.org/web/20150304192426/http://www.asam.org/docs/default-source/advocacy/aaam_implications-for-opioid-addiction-treatment_final. Accessed on December 22, 2014.
- 33.Cunningham PJ. State Variation in Primary Care Physician Supply: Implications for Health Reform Medicaid Expansions. Available online at https://web.archive.org/web/20110402000140/http://www.hschange.com/CONTENT/1192/1192.pdf. Accessed on December 1, 2015.
- 41.Westat. The SAMJSA Evaluation of the Impact of the Data Waiver Program: Summary Report (Task Order 277–00-6111). Available online at https://web.archive.org/web/20111210211241/http://buprenorphine.samhsa.gov/FOR_FINAL_summaryreport_colorized.pdf. Accessed on August 27, 2009.
- 49.Sommers AS, Paradise J, Miller C. Physician willingness and resources to serve more Medicaid patients: Perspectives from primary care physicians. Medicare & Medicaid Research Review. 2011;1(2):doi: https://doi.org/10.5600/mmrr.5001.5602.a5601.
- 50.Cunningham P, May J. Medicaid Patients Increasingly Concentrated Among Physicians. Available online at https://web.archive.org/web/20061029231320/http://hschange.com/CONTENT/866/866.pdf. Accessed on November 30, 2015.
- 51.Rosenbaum S. Racial and ethnic disparities in healthcare: Issues in the design, structure, and administration of federal healthcare financing program supported through direct public funding. In: Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2003:664–698.Google Scholar
- 52.Pfeffer J. A resource dependence perspective on intercorporate relations. In: Mizruchi MS, Schwartz M, eds. Intercorporate Relations: The Structural Analysis of Business., Cambridge : Cambridge University Press; 1987:25–55.Google Scholar
- 53.Pfeffer J. New Directions for Organization Theory: Problems and Prospects. New York: Oxford University Press; 1997.Google Scholar
- 54.Dillman DA. Mail and internet surveys: The tailored design method. 2nd ed. Hoboken, N.J.: Wiley; 2007.Google Scholar
- 55.Henry J. Kaiser Family Foundation. Status of State Action on the Medicaid Expansion Decision, 2014. Available online at https://web.archive.org/web/20140617233352/; http://kff.org/health-reform/state-indicator/state-activity-around-expanding-medicaid-under-the-affordable-care-act/. Accessed on June 17, 2014.
- 56.Henry J. Kaiser Family Foundation. Health Insurance Coverage of the Total Population. Available online at https://web.archive.org/web/20140712184316/http://kff.org/other/state-indicator/total-population/. Accessed on May 13, 2014.
- 57.Henry J. Kaiser Family Foundation. Distribution of Total Population by Federal Poverty Level. Available online at https://web.archive.org/web/20140516085839/http://kff.org/other/state-indicator/distribution-by-fpl/. Accessed on January 24, 2014.
- 59.United States Census Bureau. State totals: Vintage 2014. Available online at https://web.archive.org/web/20150627072143/; http://www.census.gov/popest/data/state/totals/2014/index.html. Accessed on August 12, 2015.
- 66.StataCorp. Stata Multiple-Imputation Reference Manual, Release 15. College Station, TX: StataCorp; 2017.Google Scholar
- 69.Clemans-Cope L, Epstein M, Kenney GM. Rapid Growth in Medicaid Spending on Medications to Treat Opioid Use Disorder And Overdose. Available online at https://web.archive.org/web/20170710140634/; http://www.urban.org/sites/default/files/publication/91521/2001386-rapid-growth-in-medicaid-spending-on-medications-to-treat-opioid-use-disorder-and-overdose_3.pdf. Accessed on August 24, 2017.
- 70.Henry J. Kaiser Family Foundation. Health Reform Implementation Timeline. Available online at http://kff.org/interactive/implementation-timeline/. Accessed on May 1, 2014.